Skip to main content
Top
Published in: Clinical Rheumatology 3/2012

01-03-2012 | Original Article

The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus

Authors: Maryam Rastin, Mohammad Reza Hatef, Nafisseh Tabasi, Mahmoud Mahmoudi

Published in: Clinical Rheumatology | Issue 3/2012

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a disease with unknown etiology. The pathologic role of sex hormones and apoptosis in SLE has often been discussed. We studied the effects of estradiol in the pathway of induced apoptosis in Iranian SLE patients. T lymphocytes from 35 SLE patients and 20 age-matched controls were isolated and cultured in the presence of 10−8 M 17-β estradiol. The expression levels of Fas, Fas ligand (FasL), Bcl-2, caspase-8, and caspase-9 mRNAs were determined semiquantitatively in comparison to the expression level of beta actin RNA. Estradiol exposure did not have any significant effects on the expression levels of Fas, Bcl-2, and caspase-9 in SLE patients and controls. However, the expression levels of FasL and caspase-8 were significantly increased in SLE patients, but not in controls. This suggests the probable involvement of extrinsic apoptosis pathway in estradiol-induced apoptosis in SLE.
Literature
1.
go back to reference Lockshin MD (2002) Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus 11:662–666PubMedCrossRef Lockshin MD (2002) Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus 11:662–666PubMedCrossRef
2.
go back to reference Whitacre CC (2002) Sex differences in autoimmune disease. Nat Immunol 2:777–780CrossRef Whitacre CC (2002) Sex differences in autoimmune disease. Nat Immunol 2:777–780CrossRef
3.
go back to reference Funauchi M, Sugiyama M, Sukyoo B et al (2001) A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 10:284–288PubMedCrossRef Funauchi M, Sugiyama M, Sukyoo B et al (2001) A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 10:284–288PubMedCrossRef
4.
go back to reference Robal E, Sysa-Jodrzejowska A, Robak T, Smolewski P (2006) Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 25:225–233CrossRef Robal E, Sysa-Jodrzejowska A, Robak T, Smolewski P (2006) Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 25:225–233CrossRef
6.
go back to reference Herrmann M, Voll RE, Kaden JR (2000) Etiopathogenesis of systemic lupus erythematosus. Immunol Today 21(9):424–426PubMedCrossRef Herrmann M, Voll RE, Kaden JR (2000) Etiopathogenesis of systemic lupus erythematosus. Immunol Today 21(9):424–426PubMedCrossRef
7.
go back to reference Rider V, Abdou NI (2001) Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1:1009–1024PubMedCrossRef Rider V, Abdou NI (2001) Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1:1009–1024PubMedCrossRef
8.
go back to reference Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, Takamori K, Ogawa H (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 26:1675–1678PubMedCrossRef Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, Takamori K, Ogawa H (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 26:1675–1678PubMedCrossRef
9.
go back to reference Shames RS (2002) Gender differences in the development and function of the immune system. J Adoles Health 305:59–70CrossRef Shames RS (2002) Gender differences in the development and function of the immune system. J Adoles Health 305:59–70CrossRef
10.
go back to reference Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef
11.
go back to reference Sekigawa I, Naito T, Hira K et al (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef Sekigawa I, Naito T, Hira K et al (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef
12.
go back to reference Cutolo M, Capellino S, Sulli A et al (2006) Estrogen and autoimmune diseases. Ann N Y Acad Sci 1089:538–547PubMedCrossRef Cutolo M, Capellino S, Sulli A et al (2006) Estrogen and autoimmune diseases. Ann N Y Acad Sci 1089:538–547PubMedCrossRef
13.
14.
go back to reference Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M (2007) Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J Immunol 4:110–115PubMed Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M (2007) Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J Immunol 4:110–115PubMed
15.
go back to reference Jenkins JK, Suwannaroj S, Elbourne KB, Ndebele K, McMurray RW (2001) 17-β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and Cyclin A. Int Immunopharm 1:1897–1911CrossRef Jenkins JK, Suwannaroj S, Elbourne KB, Ndebele K, McMurray RW (2001) 17-β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and Cyclin A. Int Immunopharm 1:1897–1911CrossRef
16.
go back to reference Wang H, Xu J, Ji X et al (2005) The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 235:117–121PubMedCrossRef Wang H, Xu J, Ji X et al (2005) The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 235:117–121PubMedCrossRef
17.
go back to reference Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F (2006) Abnormal Fas/FasL and caspase-3 mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 239:121–128PubMedCrossRef Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F (2006) Abnormal Fas/FasL and caspase-3 mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 239:121–128PubMedCrossRef
18.
go back to reference Krueger A, Fas SC, Baumann S, Krammer PH (2003) Role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193:58–69PubMedCrossRef Krueger A, Fas SC, Baumann S, Krammer PH (2003) Role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193:58–69PubMedCrossRef
19.
go back to reference Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163:49–62PubMedCrossRef Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163:49–62PubMedCrossRef
20.
go back to reference Griffith JS, Jensen SM, Lucenford JK et al (1997) Evidence for the genetic control of estradiol-regulated responses. Am J Pathol 150:2223–2230PubMed Griffith JS, Jensen SM, Lucenford JK et al (1997) Evidence for the genetic control of estradiol-regulated responses. Am J Pathol 150:2223–2230PubMed
21.
go back to reference Lorenz HM, Grunke M, Hieronymus T, Kuhnel A, Manger B, Kalden JR (1997) In vitro apoptosis and expression of apoptosis related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 40:306–317PubMedCrossRef Lorenz HM, Grunke M, Hieronymus T, Kuhnel A, Manger B, Kalden JR (1997) In vitro apoptosis and expression of apoptosis related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 40:306–317PubMedCrossRef
22.
go back to reference Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Anti-CD3 induced and anti-Fas induced apoptosis in systemic lupus erythematosus (SLE). Clin Exp Immunol 123:127–135PubMedCrossRef Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Anti-CD3 induced and anti-Fas induced apoptosis in systemic lupus erythematosus (SLE). Clin Exp Immunol 123:127–135PubMedCrossRef
23.
go back to reference Mor G, Sapi E, Abrahams VM et al (2003) Interaction of estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114–122PubMed Mor G, Sapi E, Abrahams VM et al (2003) Interaction of estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114–122PubMed
24.
go back to reference Do Y, Ryu S, Nagarkatti M, Nagarkatti PS (2002) Role of death receptor pathway in estradiol-induced T cell apoptosis in vivo. Toxicol Sci 70:63–72PubMedCrossRef Do Y, Ryu S, Nagarkatti M, Nagarkatti PS (2002) Role of death receptor pathway in estradiol-induced T cell apoptosis in vivo. Toxicol Sci 70:63–72PubMedCrossRef
25.
go back to reference Bynoe MS, Grimaldi CM, Diamond B (2000) Estrogen up-regulates bcl-2 and blocks tolerance induction of Naïve B cells. Proc Natl Acad Sci USA 97:2703–2708PubMedCrossRef Bynoe MS, Grimaldi CM, Diamond B (2000) Estrogen up-regulates bcl-2 and blocks tolerance induction of Naïve B cells. Proc Natl Acad Sci USA 97:2703–2708PubMedCrossRef
26.
go back to reference Cutolo M, Sulli A, Seriolo B, Accardo S, Matti AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheum 13:217–222 Cutolo M, Sulli A, Seriolo B, Accardo S, Matti AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheum 13:217–222
Metadata
Title
The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus
Authors
Maryam Rastin
Mohammad Reza Hatef
Nafisseh Tabasi
Mahmoud Mahmoudi
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1821-3

Other articles of this Issue 3/2012

Clinical Rheumatology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine